155 related articles for article (PubMed ID: 20168159)
1. Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?
Sobel JD
Crit Care Med; 2010 Mar; 38(3):990-2. PubMed ID: 20168159
[No Abstract] [Full Text] [Related]
2. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
[TBL] [Abstract][Full Text] [Related]
3. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
4. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
5. Invasive Candida infections: the changing epidemiology.
Marr KA
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):9-14. PubMed ID: 15682589
[TBL] [Abstract][Full Text] [Related]
6. Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
Pasqualotto AC; Zimerman RA; Alves SH; Aquino VR; Branco D; Wiltgen D; do Amaral A; Cechinel R; Colares SM; da Rocha IG; Severo LC; Sukiennik TC
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):898-9. PubMed ID: 18785850
[No Abstract] [Full Text] [Related]
7. Candida glabrata fungemia: experience in a tertiary care center.
Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
[TBL] [Abstract][Full Text] [Related]
8. [Changes in epidemiology of opportunistic infections due to Candida].
Odds FC
Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300
[No Abstract] [Full Text] [Related]
9. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
10. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
Marchetti O; Bille J; Fluckiger U; Eggimann P; Ruef C; Garbino J; Calandra T; Glauser MP; Täuber MG; Pittet D;
Clin Infect Dis; 2004 Feb; 38(3):311-20. PubMed ID: 14727199
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
15. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
16. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
Fridkin SK; Kaufman D; Edwards JR; Shetty S; Horan T
Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia.
Tumbarello M; Posteraro B; Trecarichi EM; Sanguinetti M
Arch Intern Med; 2009 Aug; 169(15):1444-5; author reply 1445. PubMed ID: 19667313
[No Abstract] [Full Text] [Related]
18. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.
Blumberg HM; Jarvis WR; Soucie JM; Edwards JE; Patterson JE; Pfaller MA; Rangel-Frausto MS; Rinaldi MG; Saiman L; Wiblin RT; Wenzel RP;
Clin Infect Dis; 2001 Jul; 33(2):177-86. PubMed ID: 11418877
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
20. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
